Fundraising FoxNanoVibronix
Elmsford, US · Delaware corporation
Find your way into NanoVibronix
Sign up to see every warm intro you have to NanoVibronix
- Paths you didn't know you had: your email and LinkedIn already hold routes to the NanoVibronix team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
JC
James CardwellChief Financial Officer
SB
Stephen BrownFormer Chief Financial Officer
Board
Funding
SEC filings, press & company announcements$32.3M disclosed across 14 of 17 rounds · 2003–2025
- Undisclosed amountregistered direct offeringSep 2025Source ↗
▶$13.5MraisedSep 2023 · 1 investors · BiotechnologyRule 506(b)
▶$13.5MraisedSep 2023 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Stephen BrownExecutive Officer
- Michael FergusonDirector
- Maria SchroederDirector
- Christopher FashekDirector
- Harold JacobDirector
- Martin GoldsteinDirector
- Brian MurphyExecutive Officer, Director
- Thomas R. MikaDirector
- Aurora CassirerDirector
- Offering amount
- $13.5M
- Amount sold
- $13.5M
- Sales commissions
- $375K
- Placement agents
- H.C. Wainwright & Co., LLC
- First sale
- Aug 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$250KraisedJun 2022 · 1 investors · BiotechnologyRule 506(b)
▶$250KraisedJun 2022 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Stephen BrownExecutive Officer
- Brian MurphyExecutive Officer, Director
- Aurora CassirerDirector
- Christopher FashekDirector
- Mika R. ThomasDirector
- Harold JacobExecutive Officer, Director
- Maria SchroederDirector
- Martin GoldsteinDirector
- Michael FergusonDirector
- Offering amount
- $250K
- Amount sold
- $250K
- First sale
- Jun 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.3MraisedFeb 2021 · 3 investors · BiotechnologyRule 506(b)
▶$1.3MraisedFeb 2021 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Brian MurphyExecutive Officer, Director
- Stephen BrownExecutive Officer
- Harold JacobExecutive Officer, Director
- Christopher FashekDirector
- Martin GoldsteinDirector
- Michael FergusonDirector
- Thomas MikaDirector
- Offering amount
- $1.3M
- Amount sold
- $1.3M
- First sale
- Jan 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$6.6MraisedDec 2020 · 13 investors · BiotechnologyRule 506(b)
▶$6.6MraisedDec 2020 · 13 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Stephen BrownExecutive Officer
- Michael FergusonDirector
- Harold JacobExecutive Officer, Director
- Brian MurphyExecutive Officer, Director
- Martin GoldsteinDirector
- Christopher FashekDirector
- Thomas MikaDirector
- Offering amount
- $6.6M
- Amount sold
- $6.6M
- Sales commissions
- $595K
- Placement agents
- H.C. Wainwright & Co., LLC
- First sale
- Dec 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶Undisclosed amountofferedAug 2020 · 1 investors · BiotechnologyRule 506(b)
▶Undisclosed amountofferedAug 2020 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Brian MurphyExecutive Officer, Director
- Thomas MikaDirector
- James CardwellExecutive Officer
- Martin GoldsteinDirector
- Harold JacobExecutive Officer, Director
- Christopher FashekDirector
- Stephen BrownExecutive Officer
- Michael FergusonDirector
- First sale
- Aug 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$450KraisedJul 2020 · 1 investors · BiotechnologyRule 506(b)
▶$450KraisedJul 2020 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- James CardwellExecutive Officer
- Harold JacobExecutive Officer, Director
- Michael FergusonDirector
- Stephen BrownExecutive Officer
- Brian MurphyExecutive Officer, Director
- Martin GoldsteinDirector
- Thomas MikaDirector
- Christopher FashekDirector
- Offering amount
- $450K
- Amount sold
- $450K
- First sale
- Jun 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$100KraisedApr 2017 · 1 investors · BiotechnologyRule 506(b)
▶$100KraisedApr 2017 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michael FergusonDirector
- Christopher FashekDirector
- William SternExecutive Officer, Director
- Thomas MikaDirector
- Jona ZumerisExecutive Officer, Director
- Stephen BrownExecutive Officer
- Martin GoldsteinDirector
- Brian MurphyExecutive Officer, Director
- Harold JacobExecutive Officer, Director
- Offering amount
- $500K
- Amount sold
- $100K
- First sale
- Mar 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$250KraisedApr 2017 · 3 investors · BiotechnologyRule 506(b)
▶$250KraisedApr 2017 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Martin GoldsteinDirector
- Harold JacobExecutive Officer, Director
- Stephen BrownExecutive Officer
- Brian MurphyExecutive Officer, Director
- Thomas MikaDirector
- William SternExecutive Officer, Director
- Jona ZumerisExecutive Officer, Director
- Christopher FashekDirector
- Michael FergusonDirector
- Offering amount
- $250K
- Amount sold
- $250K
- First sale
- Mar 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has NanoVibronix raised?
- NanoVibronix has disclosed $32.3M raised across 14 of its 17 known rounds.
- Where is NanoVibronix headquartered?
- NanoVibronix is headquartered in Elmsford, US.